Venous thromboembolism and bleeding after total knee and hip arthroplasty: Findings from the Spanish national discharge database

Thrombosis and Haemostasis

Volumn 105, Issue 4, 2011, Pages 610-615

  Guijarro, Ricardo ^a   Montes, Julio ^b   Roman, Carlos San ^c   Arcelus, Juan Ignacio ^d   Barillari, Giovanni ^e   Granero, Xavier ^f   Monreal, Manuel ^f  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL DO MEIXOEIRO   (Spain)

^c Especialidad en Oftalmología Hospital Comarcal de la Axarquía Vélez Málaga Málaga   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e UNIVERSITY HOSPITAL OF UDINE   (Italy)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Orthopaedics; Prophylaxis; Pulmonary embolism; Surgery; Venous thrombosis

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; ELECTIVE SURGERY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEMATOMA; HIP ARTHROPLASTY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OBESITY; POSTOPERATIVE HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SPAIN; SURGICAL MORTALITY; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM; WOUND INFECTION;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; DATABASES, FACTUAL; FEMALE; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RISK; SPAIN; SURVIVAL ANALYSIS; VENOUS THROMBOEMBOLISM;

EID: 79955413966     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-10-0645     Document Type: Article

References (26)

1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism. American College of Chest Physicians evidence- based clinical practice guidelines (8th Edition). Chest 2008; 6: 381S-453S.
2. American Academy of Orthopaedic Surgeons clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. Adopted by the American Academy of Orthopaedic Surgeons Board of Directors May 2007. Available at: www.aaos.org/research/guidelines/PE_guideline.pdf. Accessed March 30, 2009.
3. Haas SB, Barrack MPH, Westrich G, et al. Venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 2008; 90: 2764-2780.
4. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health service, US Dept of Health and Human Services; 1988.
5. Johnson R, Green JR, Charnley J. Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin Orthop Relat Res 1977; 127: 123-132.
6. Maynard MJ, Sculco TP, Ghelman B. Progression and regression of deep vein thrombosis after total knee arthroplasty. Clin Orthop 1991; 273: 125-130.
7. Huber O, Bounameaux H, Borst F, et al. Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127: 310-313.
8. Sharrock NE, Cazan MG, Hargett MJL, et al. Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg 1995; 80: 242-248.
9. White RH, Romano PS, Zhou H, et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158: 1525-1531.
10. Rahme E, Dasgupta K, Burman M, et al. Postdischarge thromboprophylaxis and mortality risk after hip- or knee-replacement surgery. CMAJ 2008; 178: 1545-1554.
11. Brotman DJ, Jaffer AK, Hurbanek JG, et al. Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty. Thromb Haemost 2004; 92: 1012-1017.
12. Memtsoudis SG, Besculides MC, Gaber L, et al. Risk factors for pulmonary embolism after hip and knee arthroplasty: A population-based study. Intern Orthopaedics 2009; 33: 1739-1745.
13. Monreal M, Peidró L, Resines C, et al., NETCOT Investigators. Limited diagnostic workup for deep vein thrombosis after major joint surgery: Findings from a prospective, multicentre, cohort study. Thromb Haemost 2008; 99: 1112-1115.
14. Gendelman DLD, Maheshwari AV, Boutary M, et al. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. J Bone Joint Surg (Am) 2007; 89: 264-257.
15. Pedersen AB, Sorensen HT, Mehnert F, et al. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg (Am) 2010; 92: 2156-2164.
16. Burnett RSJ, Clohisy JC, Wright RW, et al. Failure of the American College of Chest Physicians-1A protocol for Lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty 2007; 22: 317-324.
17. Qadan M, Tyson M, McCafferty MH, et al. Venous thromboembolism in elective operations: balancing the choices. Surgery 2008; 144: 654-661.
18. Sharrock NE, Gonzalez Della Valle A, Go G, et al. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 2008; 466: 714-721.
19. Warwick D, Dahl OE, Fisher WD. Orthopaedic thromboprophylaxis. Limitations of current guidelines. J Bone Joint Surg (Br) 2008; 90: 127-132.
20. Eikelboom JW, Karthikeyan G, Fagel N, et al. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ. What are the implications for clinicians and patients? Chest 2009; 135: 513-520.
21. Cushner FD, Nett MP. Unanswered questions, unmet needs in venous thromboprophylaxis. Orthopedics 2009; 32 (12 Suppl): 62-66.
22. Lachiewicz PF. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty. Orthopedics 2009; 32 (12 Suppl): 74-78.
23. Struijk-Mulder MC, Ettema HB, Verheyen CC, et al. Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery. J Thromb Haemost 2010; 8: 678-683.
24. Eriksson BI, Borris LC, Friedman RJ, et al.; RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008; 358: 2765-2775.
25. Lassen MR, Ageno W, Borris LC, et al.; RECORD3 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008; 358: 2776-2786.
26. Lotke PA. Rivaroxaban for thromboprophylaxis. N Engl J Med 2008; 359: 2174.